Literature DB >> 12757895

Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion.

Ichiro Sakata1, Mami Yamazaki, Kinji Inoue, Yujiro Hayashi, Kenji Kangawa, Takafumi Sakai.   

Abstract

Growth hormone secretagogue receptor (GHS-R) is widely expressed in various regions of the body, such as the brain, pituitary gland, heart and gastrointestinal tract. Recently, ghrelin, an endogenous ligand for GHS-R, was found in the rat stomach, and several studies have suggested that ghrelin acts via the vagal afferent nerve. In this study, we studied the expression of GHS-R mRNA in the rat nodose ganglion by reverse transcriptase-polymerase chain reaction and in situ hybridization, the results of which clearly demonstrated the presence of GHS-R mRNA and GHS-R producing cells in the rat nodose ganglion. We also studied the retrograde tracing of nodose ganglion cells to the stomach and found that some GHS-R mRNA-expressing cells contain the retrograde rebelling. Our results provide direct morphological evidence that GHS-R is produced in afferent neurons of the nodose ganglion and suggest that ghrelin signals from the stomach are transmitted to the brain via vagal afferent nerves.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757895     DOI: 10.1016/s0304-3940(03)00294-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

1.  Ghrelin attenuates brain injury after traumatic brain injury and uncontrolled hemorrhagic shock in rats.

Authors:  Lei Qi; Xiaoxuan Cui; Weifeng Dong; Rafael Barrera; Jeffrey Nicastro; Gene F Coppa; Ping Wang; Rongqian Wu
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 2.  Electrophysiological analysis of circuits controlling energy homeostasis.

Authors:  Masoud Ghamari-Langroudi
Journal:  Mol Neurobiol       Date:  2012-02-14       Impact factor: 5.590

3.  Diet-induced adaptation of vagal afferent function.

Authors:  Stephen Kentish; Hui Li; Lisa K Philp; Tracey A O'Donnell; Nicole J Isaacs; Richard L Young; Gary A Wittert; L Ashley Blackshaw; Amanda J Page
Journal:  J Physiol       Date:  2011-11-07       Impact factor: 5.182

4.  KATP channels in the nodose ganglia mediate the orexigenic actions of ghrelin.

Authors:  Gintautas Grabauskas; Xiaoyin Wu; Yuanxu Lu; Andrea Heldsinger; Il Song; Shi-Yi Zhou; Chung Owyang
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

Review 5.  The central nervous system sites mediating the orexigenic actions of ghrelin.

Authors:  B L Mason; Q Wang; J M Zigman
Journal:  Annu Rev Physiol       Date:  2013-10-02       Impact factor: 19.318

6.  Enhanced gastric ghrelin production and secretion in rats with gastric outlet obstruction.

Authors:  Eisuke Iwasaki; Hidekazu Suzuki; Tatsuhiro Masaoka; Toshihiro Nishizawa; Hiroshi Hosoda; Kenji Kangawa; Toshifumi Hibi
Journal:  Dig Dis Sci       Date:  2011-11-04       Impact factor: 3.199

7.  Influence of ghrelin on interdigestive gastrointestinal motility in humans.

Authors:  J Tack; I Depoortere; R Bisschops; C Delporte; B Coulie; A Meulemans; J Janssens; T Peeters
Journal:  Gut       Date:  2005-10-10       Impact factor: 23.059

8.  Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis.

Authors:  Kavin G Shah; Rongqian Wu; Asha Jacob; Steven A Blau; Youxin Ji; Weifeng Dong; Corrado P Marini; Thanjavur S Ravikumar; Gene F Coppa; Ping Wang
Journal:  Mol Med       Date:  2009-09-18       Impact factor: 6.354

Review 9.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

10.  Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Haichao Wang; Steven A Blau; Thanjavur S Ravikumar; Ping Wang
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.